β-lactamase production in Provotella and in vitro susceptibilities to selected β-lactam antibiotics

被引:19
作者
Dubreuil, L
Behra-Miellet, J
Vouillot, C
Bland, S
Sedallian, A
Mory, F
机构
[1] Fac Pharm, F-59006 Lille, France
[2] Nancy Univ Hosp, Nancy, France
关键词
Provotella; beta-lactamase production; antibiotic resistance;
D O I
10.1016/S0924-8579(02)00352-7
中图分类号
R51 [传染病];
学科分类号
100401 [流行病与卫生统计学];
摘要
This study looked for P-lactamase production in 100 Provotella isolates. MICs were determined for amoxycillin, ticarcillin, amoxycillin+clavulanate, cephalothin, cefuroxime, cefixime, cefpodoxime and cefotaxime using the reference agar dilution method (standard M11 A4, NCCLS). Beta-lactamase activity was detected in 58 of the 100 isolates, 24 of 46 black-pigmented Provotella and 34 of 54 non-pigmented Provotella. All beta-lactamase-negative strains were susceptible to all beta-lactam antibiotics with the exception of cefuroxime and cefixime. Overall, resistance rates of Provotella strains were lower for ticarcillin (8%) and celefotaxime (12%) than for the other cephalosporins. All Provotella isolates were susceptible to amoxyillin and were all inhibited by 2 mg/l or less amoxcillin. (C) 2002 Elsevier Science B.V. and the International Society of Chemotherapy. All rights reserved.
引用
收藏
页码:267 / 273
页数:7
相关论文
共 25 条
[1]
[Anonymous], NCCLS PUBL
[2]
EVALUATION OF 2 METHODS FOR RAPID TESTING FOR BETA-LACTAMASE PRODUCTION IN BACTEROIDES AND FUSOBACTERIUM [J].
APPELBAUM, PC ;
SPANGLER, SK ;
JACOBS, MR .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1990, 9 (01) :47-50
[3]
APPELBAUM PE, 1990, ANTIMICROB AGENTS CH, V39, P2169
[4]
BETA-LACTAMASE-PRODUCING ISOLATES OF BACTEROIDES SPECIES FROM CHILDREN [J].
BROOK, I ;
CALHOUN, L ;
YOCUM, P .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1980, 18 (01) :164-166
[5]
DUBREUIL L, 1999, ANTIBIOTIQUES, V1, P147
[6]
FELMINGHAM D, 2000, 40 INT C ANT AG CHEM
[7]
Prevalence of β-lactamase-producing strains among 149 anaerobic gram-negative rods isolated from periodontal pockets [J].
Fosse, T ;
Madinier, I ;
Hitzig, C ;
Charbit, Y .
ORAL MICROBIOLOGY AND IMMUNOLOGY, 1999, 14 (06) :352-357
[8]
Activities of telithromycin (HMR 3647, RU 66647) compared to those of erythromycin, azithromycin, clarithromycin, roxithromycin, and other antimicrobial agents against unusual anaerobes [J].
Goldstein, EJC ;
Citron, DM ;
Merriam, CV ;
Warren, Y ;
Tyrrell, K .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (11) :2801-2805
[9]
GOLDSTEIN EJC, 2001, INT S NEW QUIN ED
[10]
GROLLIER G, 1994, PATHOL BIOL, V42, P498